Richard Burr is named as a lobbyist on federal disclosure filings for 26 clients through Dla Piper LLP (us). The most recent filing naming them posted in October 2026. Issues reported include Health Issues, Medical/Disease Research/Clinical Labs, Education and Taxation/Internal Revenue Code.
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | DLA PIPER LLP (US) | Q3 2026 | Trade (domestic/foreign), Budget/Appropriations, Medicare/Medicaid |
| HADRON ENERGY, INC. | DLA PIPER LLP (US) | Q3 2026 | Energy/Nuclear |
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | DLA PIPER LLP (US) | Q3 2026 | Education |
| PIVOTAL HEALTH | DLA PIPER LLP (US) | Q3 2026 | Health Issues |
| BIOGEN, INC. | DLA PIPER LLP (US) | Q3 2026 | Trade (domestic/foreign), Medical/Disease Research/Clinical Labs, Taxation/Internal Revenue Code |
| WAKE FOREST UNIVERSITY | DLA PIPER LLP (US) | Q3 2026 | Taxation/Internal Revenue Code, Education |
| UNITED WAY WORLDWIDE | DLA PIPER LLP (US) | Q3 2026 | Disaster Planning/Emergencies, Health Issues, Housing |
| DUKE UNIVERSITY | DLA PIPER LLP (US) | Q3 2026 | Taxation/Internal Revenue Code, Education |
| ATLANTIC COAST CONFERENCE | DLA PIPER LLP (US) | Q3 2026 | Sports/Athletics |
| STAX ENGINEERING, INC. | DLA PIPER LLP (US) | Q3 2026 | Environment/Superfund |
| TTX COMPANY | DLA PIPER LLP (US) | Q3 2026 | Railroads |
| COALITION FOR SMARTER REGULATION OF NICOTINE | DLA PIPER LLP (US) | Q3 2026 | Tobacco, Health Issues, Budget/Appropriations |
| NAPATREE TECHNOLOGY, LLC | DLA PIPER LLP (US) | Q3 2026 | Defense |
| NOVARTIS | DLA PIPER LLP (US) | Q3 2026 | Trade (domestic/foreign), Medical/Disease Research/Clinical Labs, Taxation/Internal Revenue Code |
| NATIONAL EMPLOYMENT OPPORTUNITIES NETWORK | DLA PIPER LLP (US) | Q3 2026 | Taxation/Internal Revenue Code |
| CROWDSTRIKE, INC. | DLA PIPER LLP (US) | Q3 2026 | Homeland Security |
| REGENXBIO INC. | DLA PIPER LLP (US) | Q3 2026 | Medical/Disease Research/Clinical Labs, Health Issues |
| AVALYN PHARMA INC. | DLA PIPER LLP (US) | Q3 2026 | Medical/Disease Research/Clinical Labs, Health Issues |
| ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) | DLA PIPER LLP (US) | Q3 2026 | Medicare/Medicaid, Medical/Disease Research/Clinical Labs |
| BIOTECHNOLOGY INNOVATION ORGANIZATION | DLA PIPER LLP (US) | Q3 2026 | Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Pharmacy |
| MICHAELS STORES, INC. | DLA PIPER LLP (US) | Q2 2026 | Trade (domestic/foreign), Tariff (miscellaneous tariff bills) |
| DSRB DEVELOPMENT GROUP | DLA PIPER LLP (US) | Q2 2026 | Banking |
| PARTICULA GROUP INC. | DLA PIPER LLP (US) | Q2 2026 | Financial Institutions/Investments/Securities |
| ASSOCIATION OF AMERICAN UNIVERSITIES | DLA PIPER LLP (US) | Q1 2026 | Education |
| DUKE UNIVERSITY HEALTH SYSTEM | DLA PIPER LLP (US) | Q4 2025 | Health Issues |
| LAZARUS AI | DLA PIPER LLP (US) | Q4 2025 | Defense, Intelligence, Health Issues |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 23 | 1 |
| 2025 | 18 | 1 |
| Year | Items | Total |
|---|---|---|
| 2026 | 5 | $5K |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Richard Burr. See the Capitol Clarity rankings and method.